The South African Health Products Regulatory Authority (SAHPRA) has announced a recall of specified batches of Citro-Soda Regular following identification of a potential contamination risk at the Adcock Ingram Clayville manufacturing facility in Johannesburg. The regulatory authority is conducting a media briefing on 20 March 2026 to provide further details on the safety concern and scope of the recall.
The recall is limited to specific batches of the antacid product produced at the facility. SAHPRA has not yet disclosed the full extent of affected batches, batch numbers, or distribution regions, pending the detailed media briefing.
Consumers are advised to await SAHPRA’s official guidance regarding affected products and proper handling instructions. Healthcare providers and the public should monitor official SAHPRA channels for batch-specific information and recommendations. This is a developing story.
Source: SAHPRA to brief media on the recall of specified batches…
Was this article helpful?
